Emilio Sanseviero

AstraZeneca (Netherlands) — Netherlands

Immunology and Microbiology · Life Sciences

13h-index2.8kcitations86works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(36), Immune cells in cancer(30), Chemokine receptors and signaling(30), Immunotherapy and Immune Responses(21), Signaling Pathways in Disease(14)

Publications86 total

Supplementary Data from Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
2024Open Access
Supplementary Table 3 from Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
2024Open Access
Supplementary Table 2 from Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
2024Open Access
Data from Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
2024Open Access
Supplementary Table 1 from Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
2024Open Access
Abstract B006: Ceralasertib enhance efficacy of anti-PDL1 treatment by modulating the tumor microenvironment in a IFNAR I dependent manner.
Cancer Immunology Research·2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
Nature Communications·2024· 43 citedOpen Access
957 The ATR-inhibitor ceralasertib modulates the tumor microenvironment and improves the effect of anti-PDL1 by activating type I IFN pathway
Regular and Young Investigator Award Abstracts·2023Open Access
Data from Syntaphilin Regulates Neutrophil Migration in Cancer
2023Open Access
Supplemental Video from Syntaphilin Regulates Neutrophil Migration in Cancer
2023Open Access
Supplemental Figures and Tables from Syntaphilin Regulates Neutrophil Migration in Cancer
2023Open Access
Data from Syntaphilin Regulates Neutrophil Migration in Cancer
2023Open Access
Supplemental Figures and Tables from Syntaphilin Regulates Neutrophil Migration in Cancer
2023Open Access
Supplemental Video from Syntaphilin Regulates Neutrophil Migration in Cancer
2023Open Access
Supplementary Figure 1 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 2 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Data from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 2 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 3 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Data from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Dmitry I. Gabrilovich(28), Qin Liu(17), Xiangfan Yin(14), Andrew V. Kossenkov(13), Giorgia Benigni(13), Fabrizio Antonangeli(13), Angela Santoni(13), Andrea Ponzetta(12), Giuseppe Sciumè(12), Alessandra Zingoni(12), Maria Rosaria Ricciardi(12), Maria Teresa Petrucci(12), Giovanni Bernardini(11), Evgenii N. Tcyganov(10), Brian Nam(10), Stephen M. Douglass(9), Mitchell E. Fane(9), Ashani T. Weeraratna(9), Mark Cobbold(8), Erica L. Stone(8)